Nervio

About

Funding history · 1 round · $6.8M total

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Nervio's primary focus?

Nervio is a digital health startup that applies data science and artificial intelligence in neurophysiology to prevent avoidable paralysis and severe neurological complications during surgeries.

When was Nervio founded?

Nervio was founded in January 2020.

What was Nervio's former name?

Nervio was formerly known as Minerva Neuroscience Technologies.

How much funding has Nervio raised in total?

Nervio has raised a total of $6,750,000 USD.

When did Nervio complete its Seed funding round and who were the investors?

Nervio completed a Seed funding round in September 2025, raising $5,500,000 USD. Investors included Merchavia Holdings and eHealth Ventures.

Has Nervio received any grants?

Yes, Nervio received a grant of $1,250,000 USD from the IIA in December 2024.

Where are Nervio's main offices located?

Nervio's headquarters are in Misgav, Israel, and it also has an office in New York, NY, USA.

What is Nervio's employee count?

Nervio has 19 employees.

When did Nervio appoint Dr. Richard Vogel as US CEO?

Nervio appointed Dr. Richard Vogel as US CEO on December 19, 2024.

Which program was Nervio selected for in July 2023?

In July 2023, Nervio was one of 10 Israeli companies selected for Assuta's 'RISE With US' program.

Sectors & technology

Highlights

Tags